| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss | ||||||||
-2,070 | -1,012 | -1,711 | -2,196 | -2,030 | -889 | -1,255 | -949 | -689 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
450 | 447 | 422 | 396 | 285 | 106 | 424 | 89 | 31 |
Beneficial conversion interest expense | ||||||||
- | - | - | - | 639 | - | - | - | - |
Share-based compensation | ||||||||
81 | 103 | 112 | 171 | 3 | - | - | - | - |
Deferred rent | ||||||||
- | - | - | - | -12 | -3 | -3 | 137 | 2 |
Equity in earnings (loss) of non-consolidated affiliate | ||||||||
- | - | - | - | - | 0 | -211 | 191 | -85 |
(Increase) decrease in operating assets: | ||||||||
Accounts receivable, net | ||||||||
141 | 476 | -323 | -101 | 361 | -377 | 160 | 386 | 0 |
Other assets | ||||||||
-64 | 218 | -45 | -132 | 230 | -260 | -53 | 265 | 118 |
Security deposits | ||||||||
-51 | -51 | 10 | -67 | -3 | - | - | - | - |
Increase (decrease) in operating liabilities: | ||||||||
Accounts payable and accrued expenses | ||||||||
408 | 622 | 60 | 314 | 361 | 378 | 238 | 451 | 136 |
Patient deposits | ||||||||
102 | -623 | -502 | 376 | 485 | -396 | 256 | 485 | -22 |
Lease incentive obligation | ||||||||
- | - | -28 | -30 | -26 | -28 | -28 | 574 | -1 |
Net cash used in operating activities | ||||||||
-1,157 | -1,273 | -1,116 | -784 | -894 | -195 | -882 | -153 | -576 |
Cash flows from investing activities: | ||||||||
Purchase of property and equipment | ||||||||
7 | 511 | 298 | 347 | 42 | -826 | -0 | 1,214 | 1,191 |
Acquisition of IMAC Florida (Note 7) | ||||||||
200 | - | - | - | - | - | - | - | - |
Investment in and advances go IMAC St Louis LLC | ||||||||
- | - | - | - | - | - | - | - | 124 |
Net cash used in investing activities | ||||||||
-207 | -364 | -298 | -347 | -42 | 454 | 242 | -985 | -1,315 |
Cash flows from financing activities: | ||||||||
Proceeds from initial public offering, net of related fees | ||||||||
- | 0 | 0 | 0 | 3,839 | - | - | - | - |
Proceeds from warrants exercised | ||||||||
- | 0 | 0 | 307 | 49 | - | - | - | - |
Proceeds from issuance of common stock | ||||||||
1,403 | - | - | - | - | - | - | - | - |
Proceeds from notes payable | ||||||||
1,200 | 0 | 112 | 0 | 100 | 568 | 626 | 540 | 2,262 |
Payments on notes payable | ||||||||
256 | 36 | 32 | 27 | 27 | 44 | 47 | 80 | 20 |
Payments of debt issuance costs | ||||||||
70 | - | - | - | - | - | - | - | - |
Proceeds from line of credit | ||||||||
- | - | - | - | - | -319 | 129 | 290 | 75 |
Payments on line of credit | ||||||||
- | 0 | 150 | 0 | 150 | - | - | - | - |
Payments on finance lease obligation | ||||||||
4 | - | - | - | 4 | - | - | - | - |
Payments on capital lease obligation | ||||||||
- | - | - | - | - | - | 4 | 1 | 1 |
Net cash provided by financing activities | ||||||||
2,272 | 1,271 | -75 | 297 | 3,807 | -306 | 669 | 800 | 2,314 |
Net increase in cash | ||||||||
908 | -367 | -1,490 | -834 | 2,871 | - | - | - | - |
Net increase in cash | ||||||||
- | - | - | - | - | - | - | - | 422 |
Supplemental cash flow information: | ||||||||
Interest paid | ||||||||
27 | 0 | 66 | 0 | 30 | 51 | 45 | 32 | 23 |
Non cash financing and investing: | ||||||||
Debt discount notes payable | ||||||||
115 | - | - | - | - | - | - | - | - |